Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C29H30Cl2F2N4O2 |
| Molecular Weight | 575.477 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
NC(=O)C1CN(CC(=O)NC2=C(Cl)C=CC=C2Cl)CCN1CCCC(C3=CC=C(F)C=C3)C4=CC=C(F)C=C4
InChI
InChIKey=VWXFUOAKGNJSBI-UHFFFAOYSA-N
InChI=1S/C29H30Cl2F2N4O2/c30-24-4-1-5-25(31)28(24)35-27(38)18-36-15-16-37(26(17-36)29(34)39)14-2-3-23(19-6-10-21(32)11-7-19)20-8-12-22(33)13-9-20/h1,4-13,23,26H,2-3,14-18H2,(H2,34,39)(H,35,38)
| Molecular Formula | C29H30Cl2F2N4O2 |
| Molecular Weight | 575.477 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Protection of human, rat, and guinea-pig atrial muscle by mioflazine, lidoflazine, and verapamil against the destructive effects of high concentrations of Ca2+. | 1992-02 |
|
| A comparison of the cardioprotective effects of calcium antagonists from different classes upon ischaemic damage in the guinea-pig working heart. | 1989-07 |
|
| [Protective effects of lidoflazine and mioflazine in ischemic myocardium]. | 1988-04 |
|
| [Preventive effect of mioflazine on myocardial calcium-overload during postischemic reperfusion in the rabbit heart]. | 1988-04 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 19:17:55 GMT 2025
by
admin
on
Mon Mar 31 19:17:55 GMT 2025
|
| Record UNII |
8YF140A099
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID00868521
Created by
admin on Mon Mar 31 19:17:55 GMT 2025 , Edited by admin on Mon Mar 31 19:17:55 GMT 2025
|
PRIMARY | |||
|
8YF140A099
Created by
admin on Mon Mar 31 19:17:55 GMT 2025 , Edited by admin on Mon Mar 31 19:17:55 GMT 2025
|
PRIMARY | |||
|
5430
Created by
admin on Mon Mar 31 19:17:55 GMT 2025 , Edited by admin on Mon Mar 31 19:17:55 GMT 2025
|
PRIMARY | |||
|
C175139
Created by
admin on Mon Mar 31 19:17:55 GMT 2025 , Edited by admin on Mon Mar 31 19:17:55 GMT 2025
|
PRIMARY | |||
|
79467-23-5
Created by
admin on Mon Mar 31 19:17:55 GMT 2025 , Edited by admin on Mon Mar 31 19:17:55 GMT 2025
|
PRIMARY | |||
|
C041518
Created by
admin on Mon Mar 31 19:17:55 GMT 2025 , Edited by admin on Mon Mar 31 19:17:55 GMT 2025
|
PRIMARY | |||
|
100000080661
Created by
admin on Mon Mar 31 19:17:55 GMT 2025 , Edited by admin on Mon Mar 31 19:17:55 GMT 2025
|
PRIMARY | |||
|
CHEMBL2110980
Created by
admin on Mon Mar 31 19:17:55 GMT 2025 , Edited by admin on Mon Mar 31 19:17:55 GMT 2025
|
PRIMARY | |||
|
SUB08983MIG
Created by
admin on Mon Mar 31 19:17:55 GMT 2025 , Edited by admin on Mon Mar 31 19:17:55 GMT 2025
|
PRIMARY | |||
|
72001
Created by
admin on Mon Mar 31 19:17:55 GMT 2025 , Edited by admin on Mon Mar 31 19:17:55 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ENANTIOMER -> RACEMATE | |||
|
|
ENANTIOMER -> RACEMATE | |||
|
|
SALT/SOLVATE -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |